Showing results (51-60 of 1,246) with videos related to

Sort By:
Pageof 125
Experimental Oncology|January 5, 2026
PRE-SURGERY BLOOD CELL RATIOS AND SURVIVAL IN PATIENTS WITH MALIGNANT GLIOMASL Liubich, V Rozumenko, T Malysheva, et al.
Experimental Oncology|January 13, 2006
Influence of aconitine-containing herbal extract BC1 on proliferative and electrokinetic characteristics of endothelial cellsL V Garmanchouk, O N Pyaskovskaya, Yu V Yanish, et al.
Experimental Oncology|January 13, 2006
Activation of antitumor cytotoxic T lymphocytes by fusion of patient-derived dendritic cells with autologous osteosarcomaZ Yu, B Ma, Y Zhou, et al.
Experimental Oncology|January 13, 2006
Total proteolytic activity and levels of the main proteinase inhibitors in blood plasma of mice bearing Lewis lung carcinoma upon development of resistance to cisplatinV F Chekhun, O V Kovtonyuk, I N Todor, et al.
Experimental Oncology|January 13, 2006
Effect of landomycin E on expression of mRNA coding for transforming growth factor beta ligands and specific receptors in MCF-7 cellsR Panchuk, A Korynevska, R Stoika
Experimental Oncology|April 29, 2008
VEGF-siRNA silencing induces apoptosis, inhibits proliferation and suppresses vasculogenic mimicry in osteosarcoma in vitroJ Mei, Y Gao, L Zhang, et al.
Experimental Oncology|April 29, 2008
Effect of anticancer drugs on production of transforming growth factor and expression of p53 AND Bcl-2 proteins by MCF-7 and T47D cell lines of human breast carcinomaR S Stoika, I A Yakymovych, N I Kashchak, et al.
Experimental Oncology|April 29, 2008
The use of doxorubicine at low doses for elevation of LAK-activity toward explants and cells of MC-rhabdomyosarcoma and B16 melanoma resistant to doxorubicinN M Berezhnaya, Yu D Vinnichuk, O B Belova
Experimental Oncology|July 27, 2004
Autofluorescence of transplantable hepatoma A22 (MH-A22): prospects of tumor tissue optical biopsyMindaugas Tamosiunas, Julija Makaryceva, Jurate Labanauskiene, et al.
Experimental Oncology|January 11, 2013
Ukrain, a plant derived semi-synthetic compound, exerts antitumor effects against murine and human breast cancer and induce protective antitumor immunity in miceE N Bozeman, S Srivatsan, H Mohammadi, et al.
Pageof 125